// App-Quantinova.ai

TCT-137 : Five-Year Clinical Outcomes for Resolute Zotarolimus-Eluting Stents in Total Occlusions

Researchers

Presenter

  • Robert Yeh

Principal Investigators

  • Henning Kelbaek

  • Franz-Josef Neumann

  • Patrick Serruys

  • Stephan Windecker

  • Jorge Belardi

  • Bo Xu

  • Shubin Qiao

  • Minglei Liu

  • Sigmund Silber

Medical Centers

  • Cardiology, University Heart Center Freiburg/Bad Krozingen, Bad Krozingen, Germany

  • Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina

  • Zealand University Hospital, Roskilde, Denmark, Roskilde, Denmark

  • Santa Rosa, California, United States

  • Heart Center at the Isar, Munich, Germany

  • Fuwai Hospital, National Center for Cardiovascular Diseases, Beijing, China, Beijing, Beijing, China

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

  • University Hospital of Bern, Bern, Switzerland

  • Imperial College, London, United Kingdom

Locations

  • Germany

  • United Kingdom

  • Switzerland

  • United States

  • China

  • Denmark

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • AKT Serine

Drug/Treatment

  • ZoMaxx

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved